3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Gastrointestinal
1
Conditions
Prostatic Neoplasms
16
Neoplasm Metastasis
3
Urologic Diseases
1
Salivary Gland Neoplasms
1
Recurrence
1
Radiation Injuries
1
Prostate Cancer Metastatic
1
Oligorecurrent and Oligoprogressive Prostate Cancer Patients
1
Neoplasms
1
Neoplasm Recurrence, Local
1
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
1
Intraprostatic Prostate Cancer
1
Gastrointestinal Diseases
1
Interventions
Water
1
Stents
1
Nephrotomy
1
Nephrostomy, Percutaneous
1
Ice
1
Health Information Exchange
1
Circumcision, Male
1
Androgen Antagonists
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Urologic Diseases
×
Androgen Antagonists
×
Clear all
NCT07483658
2026-03-19
HYP-OP-RT
CHU de Quebec-Universite Laval
Phase NA
Not yet recruiting
434 enrolled